UBS O'Connor’s Clarim Acquisition Corp. Warrant CLRMW Stock Holding History

UBS O'Connor’s Portfolio CLRMW Stock Details CLRMW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-144,156	Closed	-$5K	–	849
2022 Q3	$5K	Sell	144,156 -14,492	-9%	-$1.23K	﹤0.01%	942
2022 Q2	$20K	Buy	+158,648	New	+$27.6K	﹤0.01%	911
2022 Q1	–	Sell	-205,504	Closed	-$124K	–	716
2021 Q4	$124K	Buy	205,504 +5,512	+3%	+$3.46K	﹤0.01%	812
2021 Q3	$131K	Hold	199,992	–	–	﹤0.01%	789
2021 Q2	$171K	Hold	199,992	–	–	﹤0.01%	755
2021 Q1	$117K	Buy	+199,992	New	+$138K	﹤0.01%	737

UBS O'Connor's CLRMW Position: Q4 2022 in Review

UBS O'Connor sold out of Clarim Acquisition Corp. Warrant (CLRMW) in Q4 2022, closing a stake of 144,156 shares — an estimated $5K sold.

UBS O'Connor first reported a position in CLRMW in Q1 2021 and held it in 6 quarters. The position peaked at $171K in Q2 2021. 0 funds tracked by Wall St. Rank hold CLRMW as of Q4 2022.

UBS O'Connor reported no remaining Clarim Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 144,156 Clarim Acquisition Corp. Warrant shares in Q4 2022, an estimated $5K.
UBS O'Connor first reported a position in Clarim Acquisition Corp. Warrant in Q1 2021 and held it in 6 quarters.
UBS O'Connor's Clarim Acquisition Corp. Warrant position peaked at $171K in Q2 2021.
0 funds tracked by Wall St. Rank held Clarim Acquisition Corp. Warrant as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.